Profile: Pall Corporation (PLL.N)

Pall Corporation, incorporated in July 1946, along with its subsidiaries, is a supplier of filtration, separation and purification technologies principally made by the Company using its engineering capability and fluid management, filter media, and other fluid clarification and separations equipment for the removal of solid, liquid and gaseous contaminants from a variety of liquids and gases. The Company serves customers through two business groups globally: Life Sciences and Industrial. The Life Sciences business group is focused on developing, manufacturing and selling products to customers in the medical and biopharmaceuticals marketplaces. The Industrial business group is focused on developing, manufacturing and selling products to customers in the aerospace and transportation, microelectronics and energy, and water and process technologies markets.

Life Sciences Segment

The Company’s Life Sciences technologies facilitate the process of drug discovery, development, regulatory validation and production. They are used in the research laboratory, pharmaceutical and biotechnology industries, in blood centers and in hospitals at the point of patient care. The Company’s medical products improve the safety of the use of blood products in patient care and help control the spread of infections in hospitals. Its Acrodose PL System enables blood centers to tap into the abundant, but often discarded, supply of whole blood platelets. The Company’s breathing-circuit, intravenous and point-of-use Pall-Aquasafe water filters help protects people from hospital acquired infections.

The Company sells separation systems and disposable filtration and purification technologies primarily to pharmaceutical and biotechnology companies for use by them in the development and commercialization of chemically synthesized and biologically derived drugs and vaccines. The Company provides a range of advanced filtration solutions for each critical stage of drug development through drug production. Its filtration systems and validation services assist drug manufacturers through the regulatory process and on to the market.

The Company competes with Fenwal, Inc., MacoPharma Group, Fresenius Medical Care AG & Co., Millipore Corporation, GE Healthcare, Tyco International Ltd., Teleflex Incorporated, Terumo Medical Corporation, Capital Health Inc., The Sartorius Group and CUNO.

Industrial Segment

The Company provides enabling and process enhancing technologies throughout the industrial marketplace. This includes the aerospace, transportation, microelectronics and consumer electronics, municipal and industrial water, fuels, chemicals, energy, and food and beverage markets. The Company has the capability to provide customers with integrated solutions for their process fluids.

Within the Food & Beverage market, filtration solutions are provided to the wine, beer, soft drink, bottled water and food ingredient markets. The Company sells filtration and fluid monitoring equipment to the aerospace industry for use on commercial and military aircraft, ships and land-based military vehicles to help protect critical systems and components. Commercial, military and transportation sales represented 34%, 49% and 17%, respectively, of total aerospace and transportation sales during the fiscal year ended July 31, 2009 (fiscal 2009). The Company sells filtration and purification technologies for the semiconductor, data storage, fiber optic, advanced display and materials markets.

The Company competes with CUNO, GE Infrastructure, U.S. Filter, The Sartorius Group, Parker Hannifin Corporation, Rohm and Haas Company, Donaldson Company, Inc., ESCO Technologies Inc., CLARCOR Inc., Entegris, Inc. and Mott Corporation.